Launched in 2025

Technological innovation of monomeric antigen and nano-aluminum hydroxide adjuvants.

Significantly elevated GMC of antibodies delivers stronger and longer-lasting protection.

Free of preservatives and antibiotics, no hypersensitivity reactions and vaccine-related SAE.

Pre-filled syringe design enables rapid post-trauma vaccination.